ArticleBMC geriatrics2026
Evaluation of a Frustrated Total Internal Reflection (FTIR) based balance sensor for objective fall risk assessment in older adults: a study protocol.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06767163 (Development and Applications of Daily-use Fall Risk Assessment Device to Prevent Elderly People from Falling), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Development and Applications of Daily-use Fall Risk Assessment Device to Prevent Elderly People from Falling
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundClinical fall risk assessments, such as the Fall Risk Assessment Scale for the Elderly (FRASE), often rely on subjective clinician observation. This protocol described the evaluation of “iBalance”, an AI-enabled device utilizing Frustrated Total Internal Reflection (FTIR) to objectively measure dynamic balance and predict fall risk. This study aims to validate the screening accuracy of the iBalance device and explore its feasibility for clinical integration.
methods412 adults aged 60 years and above and 10 clinical professionals will be recruited from outpatient clinics for this mixed-method study. Older adults’ fall risk will be assessed by the iBalance and clinical assessments (e.g., FRASE scale) separately, and their fall incidents will be recorded during a three-month follow-up. The iBalance captures high-resolution plantar pressure at 30 Hz. The system processes data via: (1) a machine learning model trained on extracted 3D Center of Pressure (CoP) and Center of Gravity (CoG) features; (2) a Convolutional Neural Network (CNN) for direct video data analysis; and (3) a statistical method optimized for maximum Area Under the Curve (AUC). To ensure participant safety, all the assessments will be conducted with side handrails and staff guarding to prevent falls. Individual interviews with clinical professionals will be conducted to gather insights on improving the device’s practicality and the application of clinical workflows. The primary outcome is sensitivity, specificity, and AUC of iBalance compared to the clinical assessments. Logistic regression will adjust for key confounders (age, gender, and BMI) for both fall risk factor identification and 3-month prospective fall prediction. Qualitative interviews will undergo thematic analysis. DISCUSSION: This protocol outlines a comprehensive evaluation for validating an AI-driven fall risk assessment tool. By addressing both technical screening accuracy and practical clinical utility, the study seeks to establish a standardized, objective framework for early fall intervention in geriatric care. ETHICS AND
trial registrationThis study has been approved by the IRB of The University of Hong Kong/Hong Kong Hospital Authority Hong Kong West Cluster (IRB reference number: UW 24–540). This protocol has been registered on the US ClinicalTrial.gov website (NCT06767163, registration date: January 16, 2025).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.